Glycostem is invited to participate in the investor conference Stifel Midwest One-on-One Growth Conference on 12^th November, 2020. This is a virtual 1 to 1 meeting and our CEO Troels Jordansen presents.

Glycostem attends the 2nd Annual Cell & Gene Therapy Manufacturing conference virtually. Our CEO Troels Jordansen shares Glycostem world’s first off-the-shelf NK cell-based immunotherapy in the fight against cancer.

Glycostem participates the 7^th Solebury Trout Private Company Showcase co-hosted by BMO and Davis Polk. Glycostem CEO Troels Jordansen presents virtually on Thursday 15^th Oct 2020, with featured presentation and Q&A session.

Glycostem CEO Troels Jordansen shares updates from Glycostem at Alliance for Regenerative Medicine’s 2020 Cell & Gene Virtual Meeting on the Mesa.

On 8^th October 2020, Glycostem participates 2020 ISPE Biotechnology Virtual Conference. Glycostem CDO Volker Huppert presents our GMP manufacturing method of an off-the-shelf cell therapy product.

Glycostem participates the CBIIC (China BioMed Innovation and Investment Conference) virtual roadshow on 21^st Sep 2020. Our CEO Troels Jordansen talks about the our company, pipelines and the forward-looking prospects of Glycostem.